NORTHERN TRUST CORP - UNITY BIOTECHNOLOGY INC ownership

UNITY BIOTECHNOLOGY INC's ticker is and the CUSIP is 91381U200. A total of 55 filers reported holding UNITY BIOTECHNOLOGY INC in Q4 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of UNITY BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$51,932
-10.3%
21,638
-4.7%
0.00%
Q2 2023$57,890
+61.1%
22,702
+2.9%
0.00%
Q1 2023$35,945
-56.7%
22,052
-27.2%
0.00%
Q4 2022$82,97830,2840.00%
Other shareholders
UNITY BIOTECHNOLOGY INC shareholders Q4 2022
NameSharesValueWeighting ↓
Founders Fund V Management, LLC 491,751$134,7317.85%
ARCH Venture Management, LLC 1,004,817$2,753,1990.70%
683 Capital Management, LLC 240,000$657,6000.06%
Parkman Healthcare Partners LLC 42,749$117,1320.03%
CVI Holdings, LLC 74,100$203,0340.03%
Alyeska Investment Group, L.P. 697,448$1,911,0080.02%
Arete Wealth Advisors, LLC 10,392$140,582,9700.01%
Virtu Financial LLC 20,155$550.01%
Johnson Midwest Financial, LLC 661$20.01%
Cercano Management LLC 41,238$112,9920.01%
View complete list of UNITY BIOTECHNOLOGY INC shareholders